Columbia biomedical engineers are collaborating with orthopedic surgeons to build a living replacement knee to be tested in clinical trials within five years.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
An analysis of more than 40,000 primary sensory neurons in the skin has found multiple different types, each sensing a more complex range of stimuli than previously assumed.
Spectacular images of a molecule that shuttles omega-3 fatty acids into the brain may open a doorway for delivering neurological therapeutics to the brain.
The new center builds on the school’s long-standing commitment to LGBTQ health and will study health among sexual and gender minority populations across the lifespan, with an emphasis on resilience.
The annual Vagelos Precision Medicine Pilot Grants have been awarded to five teams of VP&S researchers conducting innovative basic science, translational, and clinical research.
Programs that bring pharmacists into Black-owned barbershops could dramatically improve hypertension control and reduce heart disease disparities among Black men at a relatively modest cost.
The rapid shortening of the cell's telomeres between birth and age 3 may render telomeres particularly susceptible to environmental influences during this time, potentially influencing longevity.
A new study describes multiple ways to achieve the same health benefits from exercise—as long as your exercise “cocktail” includes plenty of light physical activity.
Brief pulses of ultrasound delivered to nerves near the kidney lowered blood pressure in people with drug-resistant hypertension, Columbia and NewYork-Presbyterian physicians have found.
Scientists at Columbia took high-res images of a heat-sensing molecule in ground squirrels that could help researchers understand how we sense temperature and lead to the design of new pain relievers.